| 000 | 01811 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518020154.0 | ||
| 264 | 0 | _c20190820 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1868-7083 | ||
| 024 | 7 |
_a10.1186/s13148-018-0605-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHe, Chao | |
| 245 | 0 | 0 |
_aElevated H3K27me3 levels sensitize osteosarcoma to cisplatin. _h[electronic resource] |
| 260 |
_bClinical epigenetics _c01 2019 |
||
| 300 |
_a8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEnhancer of Zeste Homolog 2 Protein _xgenetics |
| 650 | 0 | 4 | _aEpigenesis, Genetic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 |
_aHistone Demethylases _xgenetics |
| 650 | 0 | 4 |
_aHistones _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJumonji Domain-Containing Histone Demethylases _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMyeloid Cell Leukemia Sequence 1 Protein _xgenetics |
| 650 | 0 | 4 |
_aNuclear Proteins _xgenetics |
| 650 | 0 | 4 |
_aOsteosarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase C-alpha _xgenetics |
| 650 | 0 | 4 | _aSequence Analysis, RNA |
| 650 | 0 | 4 | _aUp-Regulation |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aSun, Jian | |
| 700 | 1 | _aLiu, Chao | |
| 700 | 1 | _aJiang, Yuhang | |
| 700 | 1 | _aHao, Yongqiang | |
| 773 | 0 |
_tClinical epigenetics _gvol. 11 _gno. 1 _gp. 8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13148-018-0605-x _zAvailable from publisher's website |
| 999 |
_c29262007 _d29262007 |
||